Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y005919 | — |
no adverse event; TE. PROQUAD was administered to one patient; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 19-Aug-2025, the patient was vaccinated with an improperly stored vaccine of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Powder and solvent for solution for injection (lot #Y005919, expiration date: 13-Mar-2026), 0.5 mL, total, (route of administration and anatomical location were not provided) as prophylaxis. The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot # and expiration date were not provided) (Product storage error). The improperly stored vaccine underwent a temperature excursion of 5 degrees Fahrenheit (F) for 1 hour and 3 minutes without previous excursions. No adverse events were reported.
Sterile diluent